norethindrone has been researched along with thromboplastin in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (57.14) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ateyeh, E; Jones, JR; Keates, JS; Perez, R; Ramasamy, N; Sawyer, PN; Solash, J; Srinivasan, S; Stein, H; Troyansky, D | 1 |
Lecompte, F; Renaud, S | 1 |
Gautheron, P; Renaud, S | 1 |
Coopland, AT; Wodzicki, AM | 1 |
Aune, B; Oian, P; Omsjø, I; Osterud, B | 1 |
Kotsopoulos, D; Malan, E; McGrath, BP; Peverill, RE; Smolich, JJ; Teede, HJ; Tipping, PG | 1 |
Brosnan, JF; Kelly, LA; Norris, LA; O'Leary, JJ; Sheppard, BL | 1 |
2 trial(s) available for norethindrone and thromboplastin
Article | Year |
---|---|
Hormone replacement therapy reduces the reactivity of monocytes and platelets in whole blood--a beneficial effect on atherogenesis and thrombus formation?
Topics: Administration, Cutaneous; Administration, Oral; Adult; Arteriosclerosis; Blood Platelets; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone; Middle Aged; Monocytes; Norethindrone; Thromboplastin; Thrombosis; Thromboxane B2; Tumor Necrosis Factor-alpha | 1995 |
Effects of combined oral hormone replacement therapy on tissue factor pathway inhibitor and factor VII.
Topics: Age Factors; Aged; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Humans; Middle Aged; Norethindrone; Normal Distribution; Progesterone Congeners; Statistics, Nonparametric; Thrombin; Thromboplastin | 2001 |
5 other study(ies) available for norethindrone and thromboplastin
Article | Year |
---|---|
Hormonal steroids: effects on the vascular system.
Topics: Animals; Aorta; Blood Circulation; Blood Coagulation; Blood Platelets; Cardiovascular System; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Dimethisterone; Dogs; Erythrocytes; Estradiol; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone; Mesenteric Arteries; Mesenteric Veins; Mestranol; Norethindrone; Norgestrel; Rats; Thromboplastin; Venae Cavae | 1975 |
Influence of pregnancy and oral contraceptives on platelets in relation to coagulation and aggregation.
Topics: Adenosine Diphosphate; Adolescent; Adult; Animals; Blood Coagulation Disorders; Blood Platelets; Cholesterol; Contraceptives, Oral; Ethynodiol Diacetate; Female; Humans; Norethindrone; Norgestrel; Platelet Adhesiveness; Pregnancy; Prothrombin Time; Rats; Thrombin; Thromboplastin | 1973 |
Role of platelet factor 3 in the hypercoagulability induced by pregnancy and oral contraceptives.
Topics: Adult; Animals; Blood Cell Count; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Platelets; Contraceptives, Oral; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Humans; Mestranol; Methods; Middle Aged; Norethindrone; Norgestrel; Phosphatidylethanolamines; Platelet Adhesiveness; Pregnancy; Prothrombin Time; Rats; Thromboplastin | 1973 |
Effect of lactation suppressants on the coagulation mechanism.
Topics: Adolescent; Adult; Blood Cell Count; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Estrogens; Factor IX; Factor VII; Factor VIII; Factor X; Female; Fibrinogen; Humans; Lactation; Mestranol; Naphthalenes; Norethindrone; Platelet Adhesiveness; Postpartum Period; Pregnancy; Prothrombin Time; Thromboplastin; Time Factors; Valerates | 1974 |
Norethisterone acetate alters coagulation gene expression in vitro in human cell culture.
Topics: Blood Coagulation; Cells, Cultured; Contraceptives, Oral, Synthetic; Estradiol; Estrone; Factor VII; Fibrinogen; Gene Expression Regulation; Hepatocytes; Human Umbilical Vein Endothelial Cells; Humans; Lipoproteins; Norethindrone; Norethindrone Acetate; Plasminogen Activator Inhibitor 1; Prothrombin; Real-Time Polymerase Chain Reaction; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thromboplastin; Time Factors; Tissue Plasminogen Activator | 2013 |